-
Somberg J. Sacubitril/Valsartan Conundrum. Cardiol Res. 2021 Jun; 12(3):131. PMID: 34046104.
-
Somberg J. Therapies for COVID-19: A Disorganized Approach. Cardiol Res. 2021 Apr; 12(2):51-52. PMID: 33738006.
-
Somberg J. Virtual Versus In-Person Learning as a Cardiologist During COVID-19 Pandemic. Cardiol Res. 2021 Feb; 12(1):1. PMID: 33447318.
-
Somberg J. The Importance of Cardiology Research. Cardiol Res. 2020 Dec; 11(6):355. PMID: 33224378.
-
Somberg JC. Van Gogh and Digitalis. Am J Cardiol. 2020 12 01; 136:164-165. PMID: 32941822.
-
Somberg JC, Vinks AA, Dong M, Molnar J. Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion. Cardiol Res. 2020 Oct; 11(5):294-304. PMID: 32849964.
-
Somberg J. Science, Politics and Hydroxychloroquine. Cardiol Res. 2020 Oct; 11(5):267-268. PMID: 32849959.
-
Shugg T, Somberg JC, Molnar J, Overholser BR. Inhibition of Human Ether-A-Go-Go-Related Gene (hERG) Potassium Current by the Novel Sotalol Analogue, Soestalol. JACC Clin Electrophysiol. 2020 07; 6(7):756-759. PMID: 32703555.
-
Somberg J. Frontiers in Cardiology Research. Cardiol Res. 2020 Jun; 11(3):140. PMID: 32494322.
-
Somberg J. Let Us Aggressively Confront the Coronavirus Pandemic. Cardiol Res. 2020 Jun; 11(3):139. PMID: 32494321.
-
Somberg J, Molnar J. What is New in Pharmacologic Therapy for Cardiac Resuscitation? Cardiol Res. 2020 Jun; 11(3):141-144. PMID: 32494323.
-
Somberg J. Let Us Do Not Forget Durability. Cardiol Res. 2020 Apr; 11(2):67. PMID: 32256912.
-
Bacaner M, Somberg J. The Bretylium Saga: A Novel "Old Drug" for Cardiac Resuscitation. Am J Cardiol. 2020 05 15; 125(10):1596-1598. PMID: 32238277.
-
Jacobson JL, Somberg JC, Nguyen HH. Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2020 Feb; 41(2):418-422. PMID: 31664485.
-
Somberg J, Molnar J. Evaluating Serious Adverse Drug Reactions. Cardiology. 2018; 139(3):202. PMID: 29444510.
-
Milan DJ, Saul JP, Somberg JC, Molnar J. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60. PMID: 27554842.
-
Somberg J, Molnar J. Adverse Reactions of Amiodarone on the Thyroid. Cardiology. 2016; 134(3):364-5. PMID: 27100465.
-
Somberg J, Molnar J. Sotalol versus Amiodarone in Treatment of Atrial Fibrillation. J Atr Fibrillation. 2016 Feb-Mar; 8(5):1359. PMID: 27909477.
-
Somberg J. Let us regulate pharmaceuticals: here we go again. Am J Ther. 2015 Nov-Dec; 22(6):409-10. PMID: 26539781.
-
Somberg J. Signing off. Am J Ther. 2015 Nov-Dec; 22(6):411. PMID: 26539782.
-
Somberg JC, Molnar J. Retrospective Evaluation on the Analgesic Activities of 2 Compounded Topical Creams and Voltaren Gel in Chronic Noncancer Pain. Am J Ther. 2015 Sep-Oct; 22(5):342-9. PMID: 26352120.
-
Somberg J. Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic Optimization. Am J Ther. 2015 Sep-Oct; 22(5):321. PMID: 26349018.
-
Molnar J, Somberg JC. Evaluation of the Effects of Different Energy Drinks and Coffee on Endothelial Function. Am J Cardiol. 2015 Nov 01; 116(9):1457-60. PMID: 26341184.
-
Somberg J. The Need for Stimulation. Am J Ther. 2015 Jul-Aug; 22(4):243. PMID: 26163821.
-
Molnar J, Somberg JC. A Rapid Method to Evaluate Cardiac Repolarization Changes: The Effect of Two Coffee Strengths on the QT Interval. Cardiology. 2015; 131(3):203-8. PMID: 25997417.
-
Somberg JC, Molnar J. Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions. Am J Ther. 2015 May-Jun; 22(3):214-21. PMID: 25859821.
-
Somberg J, Molnar J. Lesson to be learned from the renal denervation trials. Am J Ther. 2015 May-Jun; 22(3):167-70. PMID: 25943389.
-
Somberg J. Computerization in medicine. Am J Ther. 2015 Mar-Apr; 22(2):89. PMID: 25734589.
-
Somberg JC. The new year. Am J Ther. 2015 Jan-Feb; 22(1):1. PMID: 25563561.
-
Somberg JC. The failing Ebola policy. Am J Ther. 2014 Nov-Dec; 21(6):441. PMID: 25373311.
-
Somberg JC. Digoxin therapy for atrial fibrillation in the twenty-first century. Am J Ther. 2014 Sep-Oct; 21(5):325-6. PMID: 25207980.
-
Somberg J. OUS results, clinical studies and therapeutic innovation in America. Am J Ther. 2014 Jul-Aug; 21(4):233. PMID: 25007241.
-
Somberg J. International vs. hospital acquired infection. Am J Ther. 2014 May-Jun; 21(3):141. PMID: 24813977.
-
Somberg J. Courts, patents, litigation & patient care. Am J Ther. 2014 May-Jun; 21(3):142. PMID: 24813978.
-
Somberg JC, McEwen P, Molnar J. Assessment of cardiovascular and noncardiovascular medical device recalls. Am J Cardiol. 2014 Jun 01; 113(11):1899-903. PMID: 24837271.
-
Somberg J. Clinical trials and their surprises. Am J Ther. 2014 Mar-Apr; 21(2):67. PMID: 24598172.
-
Somberg JC. Guidelines for a new year. Am J Ther. 2014 Jan-Feb; 21(1):1. PMID: 24401701.
-
Somberg J. The conflict of interest charade. Am J Ther. 2013 Nov-Dec; 20(6):591. PMID: 24247032.
-
Somberg J. Health care in turmoil. Am J Ther. 2013 Sep-Oct; 20(5):459. PMID: 24670782.
-
Somberg J. The Supremes got it right. Am J Ther. 2013 Jul-Aug; 20(4):315. PMID: 23838630.
-
Somberg JC. A perspective on the support of scientific research. Am J Ther. 2013 May-Jun; 20(3):231. PMID: 23656965.
-
Somberg J, Molnar J. The dark side of implantable cardioverter defibrillator therapy. Cardiology. 2013; 124(4):213-5. PMID: 23548790.
-
Somberg JC. The cart before the horse. Am J Ther. 2013 Mar-Apr; 20(2):127. PMID: 23466617.
-
Somberg JC. Conflating the approval process and clinical research with pharmacoeconomic evaluation. Am J Ther. 2013 Jan; 20(1):1. PMID: 23299228.
-
Somberg JC. Proposed accelerated FDA approvals for special medical use. Am J Ther. 2012 Nov; 19(6):393-4. PMID: 23154227.
-
Somberg JC. Making America more competitive: a paradigm shift in drug and device development. Am J Ther. 2012 Sep; 19(5):315-6. PMID: 22964557.
-
Somberg JC. The human microbiome and therapeutics. Am J Ther. 2012 Jul; 19(4):247. PMID: 22772032.
-
Somberg J. Is there an imperative for generic profiling to hasten the age of personalized medicine. Am J Ther. 2012 May; 19(3):163. PMID: 22565850.
-
Somberg JC. Drug shortages and ensuring the U.S. supply of needed pharmaceuticals. Am J Ther. 2012 Mar; 19(2):65. PMID: 22394999.
-
Somberg J. Guidelines or 10 commandments. Am J Ther. 2012 Jan; 19(1):1. PMID: 22227614.
-
Somberg J. Drug and device trials: should we ask more. Am J Ther. 2011 Nov; 18(6):435. PMID: 22072094.
-
Somberg JC. The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients. Am J Ther. 2011 Nov; 18(6):510-7. PMID: 22072096.
-
Somberg JC. The device development pinata. Am J Ther. 2011 Sep; 18(5):339. PMID: 21912221.
-
Somberg JC. Are we facilitating therapeutic innovation? Am J Ther. 2011 Jul; 18(4):279. PMID: 21743303.
-
Somberg JC. Has the food and drug administration changed the drug approval process? Am J Ther. 2011 May; 18(3):179. PMID: 21566467.
-
Somberg JC, Preston RA, Ranade V, Cvetanovic I, Molnar J. Gender differences in cardiac repolarization following intravenous sotalol administration. J Cardiovasc Pharmacol Ther. 2012 Mar; 17(1):86-92. PMID: 21527783.
-
Somberg JC. Have we maxed out on new therapies. Am J Ther. 2011 Mar-Apr; 18(2):91. PMID: 21394000.
-
Somberg JC. Inappropriate attack on device development. Am J Ther. 2011 Mar-Apr; 18(2):91. PMID: 21393999.
-
Somberg JC. From therapeutic nihilism to therapeutic success. Am J Ther. 2011 Jan; 18(1):1. PMID: 22614049.
-
Somberg JC. Unfinished business in health care reform. Am J Ther. 2011 Jan; 18(1):1. PMID: 22614048.
-
Somberg JC. The Food and Drug Administration's paternalism. Am J Ther. 2010 Nov-Dec; 17(6):533-4. PMID: 21060255.
-
Somberg JC. The midodrine withdrawal. Am J Ther. 2010 Sep-Oct; 17(5):445. PMID: 20844343.
-
Somberg JC, Preston RA, Ranade V, Molnar J. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25. PMID: 20693799.
-
Somberg JC, Preston RA, Ranade V, Molnar J. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72. PMID: 20562595.
-
Somberg J. Device safety and effectiveness. Am J Ther. 2010 Jul-Aug; 17(4):357. PMID: 20634652.
-
Somberg J. Composite end points, black box warnings, and allegations of bias. Am J Ther. 2010 May-Jun; 17(3):233. PMID: 20479575.
-
Somberg JC. Is the device development process adequate. Am J Ther. 2010 Mar-Apr; 17(2):123-4. PMID: 20305398.
-
Somberg J, Cherubini A, Lowenthal DT, Paran E, Mecocci P, Williams LS, Senin U, Hahr AJ, Molitch ME, Cheng JW, Frishman WH, Aronow WS. Topics in clinical pharmacology: cardiovascular and diabetes mellitus. Dis Mon. 2010 Mar; 56(3):105-79. PMID: 20189498.
-
Somberg JC. The hubris of science: defending the scientific process from political agendas. Am J Ther. 2010 Jan-Feb; 17(1):1. PMID: 20090430.
-
Somberg JC. Medical isotope shortages. Am J Ther. 2009 Sep-Oct; 16(5):378. PMID: 19955856.
-
Somberg JC. New advances and new questions in cardiovascular therapeutics. Am J Ther. 2009 Sep-Oct; 16(5):375-7. PMID: 19955855.
-
Somberg J. Health care reform. Am J Ther. 2009 Jul-Aug; 16(4):281-2. PMID: 19617718.
-
Somberg J. Supporting therapeutic innovation. Am J Ther. 2009 May-Jun; 16(3):203. PMID: 19454858.
-
Molnar J, Somberg JC. Neurocardiogenic syncope. Cardiology. 2009; 114(1):47-9. PMID: 19365114.
-
Somberg JC. The extrapolation of study results in the device approval process. Am J Cardiol. 2009 May 01; 103(9):1323-4. PMID: 19406280.
-
Somberg JC. The stimulus package and medical therapeutics. Am J Ther. 2009 Mar-Apr; 16(2):105. PMID: 19262356.
-
Molnar J, Somberg JC. The dynamics of QT dispersion. Cardiology. 2009; 113(3):169-71. PMID: 19136824.
-
Somberg JC, Molnar J. The management of acute heart failure and diuretic therapy. Am J Ther. 2009 Jan-Feb; 16(1):93-7. PMID: 19142155.
-
Somberg JC. Evidence based or mechanism based therapeutics. Am J Ther. 2009 Jan-Feb; 16(1):1. PMID: 19142154.
-
Somberg JC, Molnar J. Therapeutic approaches to the treatment of edema and ascites: the use of diuretics. Am J Ther. 2009 Jan-Feb; 16(1):98-101. PMID: 19142158.
-
Molnar J, Somberg JC. The clinical pharmacology of ethacrynic acid. Am J Ther. 2009 Jan-Feb; 16(1):86-92. PMID: 19142159.
-
Somberg JC, Molnar J. The pleiotropic effects of ethacrynic acid. Am J Ther. 2009 Jan-Feb; 16(1):102-4. PMID: 19142157.
-
Lin C, Somberg T, Molnar J, Somberg J. The effects of chiral isolates of methadone on the cardiac potassium channel IKr. Cardiology. 2009; 113(1):59-65. PMID: 18984955.
-
Somberg J. The drug eluting stent challenge. Am J Ther. 2008 Nov-Dec; 15(6):505. PMID: 19127131.
-
Somberg J. Licensing to prescribe. Am J Ther. 2008 Sep-Oct; 15(5):417-8. PMID: 18806515.
-
Molnar J, Somberg JC. QT dispersion: still a useful measurement. Cardiology. 2009; 112(3):165-7. PMID: 18654080.
-
Somberg JC. The sins of ghostwriting. Am J Ther. 2008 Jul-Aug; 15(4):297-8. PMID: 18645328.
-
Nada A, Baxter S, Loraas E, Somberg JC. Incidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States. Am J Ther. 2008 May-Jun; 15(3):214-20. PMID: 18496258.
-
Somberg JC, Molnar J. The cholesterol hypothesis: questioned? Am J Ther. 2008 May-Jun; 15(3):292-5. PMID: 18496268.
-
Somberg JC. Securing the US pharmaceutical supply. Am J Ther. 2008 May-Jun; 15(3):197. PMID: 18496255.
-
Somberg J, Molnar J. Ventricular repolarization spectra. Cardiology. 2008; 111(3):207-8. PMID: 18434727.
-
Somberg JC. Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82. PMID: 18376117.
-
Somberg J. FDA user fees and innovation. Am J Ther. 2008 Mar-Apr; 15(2):97. PMID: 18356626.
-
Somberg J. Therapeutic hangups. Am J Ther. 2008 Jan-Feb; 15(1):1. PMID: 18223345.
-
Lin C, Ke X, Ranade V, Somberg J. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008; 110(3):145-52. PMID: 18057881.
-
Lin C, Ke X, Ranade V, Somberg J. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide. Cardiology. 2008; 110(3):209-16. PMID: 18057887.
-
Nada A, Somberg J. First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. Am J Ther. 2007 Nov-Dec; 14(6):594-604. PMID: 18090886.
-
Somberg J. Screening drugs for QT prolongation. Am J Ther. 2007 Sep-Oct; 14(5):419-20. PMID: 17890927.
-
Somberg J. Mandatory post marketing studies. Am J Ther. 2007 Jul-Aug; 14(4):321. PMID: 17667203.
-
Somberg J. Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel. Am J Cardiol. 2007 Sep 01; 100(5):905-6. PMID: 17719343.
-
Somberg J. Biologic generics. Am J Ther. 2007 May-Jun; 14(3):230. PMID: 17515694.
-
Cvetanovic I, Lin C, Ranade V, Keshavarzian A, Somberg J. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation. Am J Ther. 2007 May-Jun; 14(3):269-76. PMID: 17515703.
-
Somberg J. Guilt by association. Am J Ther. 2007 May-Jun; 14(3):229-30. PMID: 17515693.
-
Somberg J. The drug safety review process. Am J Ther. 2007 Mar-Apr; 14(2):119. PMID: 17414577.
-
Somberg J, Weinberger J. Late stent thrombosis: problem or not? Am J Cardiol. 2007 Apr 01; 99(7):1020-3. PMID: 17398205.
-
Somberg J. The report of the Institute of Medicine on drug safety. Am J Ther. 2007 Jan-Feb; 14(1):1-2. PMID: 17303967.
-
Somberg J. The hypertension peril and drug development. Am J Ther. 2007 Jan-Feb; 14(1):2. PMID: 17303968.
-
Cvetanovic I, Ranade V, Molnar J, Whelton A, Somberg J. The evaluation of the diuretic action of parenteral formulations of metolazone. Am J Ther. 2007 Jan-Feb; 14(1):25-9. PMID: 17303972.
-
Somberg J. Physician specific prescribing information. Am J Ther. 2006 Nov-Dec; 13(6):465. PMID: 17122524.
-
Lin C, Ke X, Cvetanovic I, Ranade V, Somberg J. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Cardiology. 2007; 108(1):18-27. PMID: 16960444.
-
Somberg J. Off-label promotion. Am J Ther. 2006 Sep-Oct; 13(5):387. PMID: 16988530.
-
Somberg J. Surrogate endpoints and drug approval. Am J Ther. 2006 Sep-Oct; 13(5):388. PMID: 16988531.
-
Somberg J. Genetic drug targeting. Am J Ther. 2006 Jul-Aug; 13(4):289-90. PMID: 16858160.
-
Molnar J, Ranade V, Cvetanovic I, Molnar Z, Somberg JC. Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment. Cardiology. 2006; 106(4):224-32. PMID: 16685129.
-
Somberg JC. Risk assessment, drug approval, and liability. Am J Ther. 2006 May-Jun; 13(3):181-2. PMID: 16772756.
-
Somberg JC. Pharmaceutical companies and medical therapeutics education. Am J Ther. 2006 Mar-Apr; 13(2):93. PMID: 16645422.
-
Somberg J, Molnar J. Letter from Konstantinos P. Letsas et al. - invited editorial comment. Cardiology. 2006; 105(3):148. PMID: 16449813.
-
Cvetanovic I, Ranade V, Lin C, Somberg J. The differential antibacterial and gastrointestinal effects of erythromycin and its chiral isolates. Am J Ther. 2006 Jan-Feb; 13(1):48-56. PMID: 16428922.
-
Somberg JC. An opportunity to distance the FDA from Washington politics. Am J Ther. 2005 Nov-Dec; 12(6):475. PMID: 16280638.
-
Ranade VV, Somberg JC. Chiral cardiovascular drugs: an overview. Am J Ther. 2005 Sep-Oct; 12(5):439-59. PMID: 16148430.
-
Somberg JC. Nesiritide: the wrong controversy. Am J Ther. 2005 Sep-Oct; 12(5):377-8. PMID: 16148421.
-
Lin C, Cvetanovic I, Ke X, Ranade V, Somberg J. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther. 2005 Jul-Aug; 12(4):328-36. PMID: 16041196.
-
Somberg J. Intellectual property. Am J Ther. 2005 Jul-Aug; 12(4):285. PMID: 16041189.
-
Somberg JC. The new drug evaluation process: risk benefit ratio. Am J Ther. 2005 May-Jun; 12(3):199-200. PMID: 15891261.
-
Somberg JC, Cao W, Cvetanovic I, Ranade VV, Molnar J. The effect of magnesium sulfate on action potential duration and cardiac arrhythmias. Am J Ther. 2005 May-Jun; 12(3):218-22. PMID: 15891264.
-
Lin C, Ke X, Cvetanovic I, Ranade V, Somberg J. The influence of extracellular acidosis on the effect of IKr blockers. J Cardiovasc Pharmacol Ther. 2005 Mar; 10(1):67-76. PMID: 15821840.
-
Somberg J. Lessons learned from the COX-2 advisory hearings. Am J Ther. 2005 Mar-Apr; 12(2):105. PMID: 15767826.
-
Somberg J. The provisional approval step. Am J Ther. 2005 Jan-Feb; 12(1):1-2. PMID: 15662285.
-
Somberg JC, Cao W, Cvetanovic I, Ranade V, Molnar J. Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) compared with Cordarone IV. Am J Ther. 2005 Jan-Feb; 12(1):9-16. PMID: 15662287.
-
Somberg JC, Molnar J. The pharmacologic treatment of heart failure. Am J Ther. 2004 Nov-Dec; 11(6):480-8. PMID: 15543089.
-
Somberg J. The politics of therapeutics. Am J Ther. 2004 Nov-Dec; 11(6):422. PMID: 15543080.
-
Somberg J. Drug trial registries. Am J Ther. 2004 Sep-Oct; 11(5):327. PMID: 15356427.
-
Somberg JC, Cvetanovic I, Ranade V, Molnar J. Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone I.v. infusion on mean arterial blood pressure in conscious dogs. Cardiovasc Drugs Ther. 2004 Sep; 18(5):345-51. PMID: 15717136.
-
Somberg J. What is a journal. Am J Ther. 2004 Jul-Aug; 11(4):243. PMID: 15266214.
-
Somberg J. Obesity therapeutics in the shadows: editorial. Am J Ther. 2004 May-Jun; 11(3):155. PMID: 15133528.
-
Somberg JC, Timar S, Bailin SJ, Lakatos F, Haffajee CI, Tarjan J, Paladino WP, Sarosi I, Kerin NZ, Borbola J, Bridges DE, Molnar J. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2004 Mar 01; 93(5):576-81. PMID: 14996582.
-
Somberg J. Who is teaching pharmacology. Am J Ther. 2004 Mar-Apr; 11(2):83-4. PMID: 14999358.
-
Somberg J. Should statins go OTC. Am J Ther. 2004 Jan-Feb; 11(1):1-2. PMID: 14704588.
-
Cobleigh M, Somberg JC. A case of herceptin cardiotoxicity. Am J Ther. 2004 Jan-Feb; 11(1):74-6. PMID: 14704598.
-
Somberg J. Therapeutics 2004. Am J Ther. 2004 Jan-Feb; 11(1):1. PMID: 14704587.
-
Somberg JC, Torres V, Keren G, Butler B, Tepper D, Kleinbaum H, Molnar J. Enhancement of myocardial vulnerability by atrial fibrillation. Am J Ther. 2004 Jan-Feb; 11(1):33-43. PMID: 14704594.
-
Somberg J. Therapeutics, drug pricing and innovation. Am J Ther. 2003 Nov-Dec; 10(6):381. PMID: 14624273.
-
Somberg JC, Molnar J. The quest for an aqueous amiodarone. Am J Ther. 2003 Nov-Dec; 10(6):458-61. PMID: 14624286.
-
Somberg J. Clinical trials registries. Am J Ther. 2003 Sep-Oct; 10(5):309-10. PMID: 12975713.
-
Somberg J. Biomarker and surrogate endpoints. Am J Ther. 2003 Jul-Aug; 10(4):239-40. PMID: 12845385.
-
Somberg JC. SARS challenges therapeutics. Am J Ther. 2003 May-Jun; 10(3):161. PMID: 12756421.
-
Somberg JC. Hypertension therapeutics in turmoil. Am J Ther. 2003 Mar-Apr; 10(2):81-2. PMID: 12629584.
-
Somberg JC. Pediatric drug development. Am J Ther. 2003 Jan-Feb; 10(1):2. PMID: 12522512.
-
Somberg JC. Clinical therapeutic conference. Am J Ther. 2003 Jan-Feb; 10(1):78-80. PMID: 12522528.
-
Somberg JC. Free exchange of ideas. Am J Ther. 2003 Jan-Feb; 10(1):1. PMID: 12522511.
-
Najeed SA, Khan IA, Molnar J, Somberg JC. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol. 2002 Nov 15; 90(10):1103-6. PMID: 12423711.
-
Somberg JC. Biologic problems. Am J Ther. 2002 Nov-Dec; 9(6):471. PMID: 12424501.
-
Somberg JC. Arrhythmia therapy. Am J Ther. 2002 Nov-Dec; 9(6):537-42. PMID: 12424515.
-
Gallik DM, Singer I, Meissner MD, Molnar J, Somberg JC. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2002 Nov 01; 90(9):964-8. PMID: 12398963.
-
Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, Timar S, Molnar J. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol. 2002 Oct 15; 90(8):853-9. PMID: 12372573.
-
Somberg JC. Restricting physician prescribing. Am J Ther. 2002 Sep-Oct; 9(5):369. PMID: 12237726.
-
Somberg JC. Genetic polymorphisms. Am J Ther. 2002 Jul-Aug; 9(4):271. PMID: 12115013.
-
Somberg JC. Old drugs, new bottles, therapeutic advantage? Am J Ther. 2002 Jul-Aug; 9(4):273-4. PMID: 12115014.
-
Somberg JC. Clinical research oversight. Am J Ther. 2002 Mar-Apr; 9(2):85. PMID: 11897921.
-
Somberg JC. The generic conundrum. Am J Ther. 2002 Mar-Apr; 9(2):87-8. PMID: 11897922.
-
Somberg JC, Molnar J. Usefulness of QT dispersion as an electrocardiographically derived index. Am J Cardiol. 2002 Feb 01; 89(3):291-4. PMID: 11809431.
-
Somberg JC. Bioterrorism 2002. Am J Ther. 2002 Jan-Feb; 9(1):3. PMID: 11782812.
-
Ranade V, Somberg JC. Rapid determination of partition coefficients between n-octanol/water for cardiovascular therapies. Am J Ther. 2002 Jan-Feb; 9(1):19-24. PMID: 11782815.
-
Somberg J, Molnar J. Atrial fibrillation and valve disease. Adv Cardiol. 2002; 39:39-48. PMID: 12060922.
-
Somberg JC. American Journal of Therapeutics. Am J Ther. 2002 Jan-Feb; 9(1):1. PMID: 11910214.
-
Somberg JC. A new therapeutic millennium [correction of millenium]. Am J Ther. 2001 Nov-Dec; 8(6):385-6. PMID: 11704776.
-
Somberg JC. A challenge to America. Am J Ther. 2001 Nov-Dec; 8(6):383. PMID: 11704775.
-
Somberg JC. Stem-cell research. Am J Ther. 2001 Sep-Oct; 8(5):307. PMID: 11550069.
-
Ranade VV, Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 2001 Sep-Oct; 8(5):345-57. PMID: 11550076.
-
Somberg JC. Class effects of pharmaceuticals and therapeutic interchangeability. Am J Ther. 2001 Jul-Aug; 8(4):221-2. PMID: 11441318.
-
Somberg JC. Do we need to accredit clinical research? Am J Ther. 2001 Jul-Aug; 8(4):223-4. PMID: 11441319.
-
Somberg JC. Proposed product labeling changes: does it really matter? Am J Ther. 2001 May-Jun; 8(3):145-6. PMID: 11344380.
-
Yelamanchi VP, Molnar J, Ranade V, Somberg JC. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22. PMID: 11304665.
-
Somberg JC. Pediatric exclusivity and genericizing pharmaceuticals. Am J Ther. 2001 Mar-Apr; 8(2):79-80. PMID: 11304660.
-
Somberg JC. Are we overregulated? Am J Ther. 2001 Jan-Feb; 8(1):1-2. PMID: 11304650.
-
Somberg JC. Clinical therapeutic conference: congestive heart failure therapy. Am J Ther. 2001 Jan-Feb; 8(1):65-72. PMID: 11304659.
-
Somberg JC. The cost of therapy. Am J Ther. 2000 Nov; 7(6):343-4. PMID: 11304640.
-
Somberg JC. Sudden death in athletes. Am J Ther. 2000 Nov; 7(6):399-403. PMID: 11304649.
-
Somberg JC. Is clinical research oversight adequate in the United States? Am J Ther. 2000 Sep; 7(5):283-4. PMID: 11317171.
-
Clark CT, Resenblatt R, Somberg JC. Neurocardiogenic syncope with Addison's disease. Am J Ther. 2000 Sep; 7(5):328-31. PMID: 11317182.
-
Somberg JC. A choice, not an echo. Am J Ther. 2000 Sep; 7(5):281. PMID: 11317170.
-
Somberg JC. Adverse drug reaction reporting. Am J Ther. 2000 Aug; 7(4):227-8. PMID: 11486155.
-
Somberg JC. Is the evidence right in evidence-based practice? Am J Ther. 2000 May; 7(3):149-50. PMID: 11317162.
-
Wolf ME, Ranade V, Molnar J, Somberg J, Mosnaim AD. Hypercalcemia, arrhythmia, and mood stabilizers. J Clin Psychopharmacol. 2000 Apr; 20(2):260-4. PMID: 10770468.
-
Somberg JC. What's gone wrong with clinical research. Am J Ther. 2000 Mar; 7(2):49-50. PMID: 11319572.
-
Somberg JC. A federal solution a regulation for all. Am J Ther. 2000 Jan; 7(1):1-2. PMID: 11319566.
-
Somberg JC. Medical judgment and therapeutics. Am J Ther. 1999 Nov; 6(6):291-2. PMID: 11329111.
-
Ranade V, Molnar J, Khokher T, Agarwal A, Mosnaim A, Somberg JC. Effect of angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther. 1999 Sep; 6(5):257-61. PMID: 11329107.
-
Somberg JC. Reorganizing the flow of scientific information: is the age of electronic journalism here? Am J Ther. 1999 Sep; 6(5):235-6. PMID: 11329103.
-
Somberg JC. International symposium on drug development. Am J Ther. 1999 Sep; 6(5):289. PMID: 11329110.
-
Somberg JC. Biomarkers and surrogate endpoints. Am J Ther. 1999 Jul; 6(4):179-80. PMID: 11329094.
-
Somberg JC, Borer JS. Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process. Am J Ther. 1999 May; 6(3):175-8. PMID: 10423661.
-
Wolf ME, Moffat M, Ranade V, Somberg JC, Lehrer E, Mosnaim AD. Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol. 1998 Oct; 18(5):420-3. PMID: 9790163.
-
Somberg JC. Reactions to prescribed drugs kill thousands annually. Am J Ther. 1998 May; 5(3):133. PMID: 10660364.
-
Tarabey R, Sukenik D, Molnar J, Somberg JC. Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion. Am Heart J. 1998 Mar; 135(3):519-22. PMID: 9506339.
-
Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, Rubie C, Hördt M, Towbin JA, Borggrefe M, Assmann G, Qu X, Somberg JC, Breithardt G, Oberti C, Funke H. KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet. 1997 Nov; 17(3):267-8. PMID: 9354783.
-
Somberg JC, Yelamanchi V, Molnar J, Aschermann M, Bernink PJ, Caspi A, Marmor A, Rabinowitz B, Reisin L, Ruzyllo W. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4. PMID: 10423637.
-
Molnar J, Rosenthal JE, Weiss JS, Somberg JC. QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment. Am J Cardiol. 1997 May 01; 79(9):1190-3. PMID: 9164883.
-
Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol. 1997 Feb 15; 79(4):508-11. PMID: 9052362.
-
Somberg JC. The Year in Review. Am J Ther. 1996 Dec; 3(12):1. PMID: 11862239.
-
Somberg JC. The Therapeutics of Hypertensive Emergency. Am J Ther. 1996 Nov; 3(11):741. PMID: 11862231.
-
Khosla S, Tarabey R, Megellas MM, Somberg JC. Approaches to Intravenous Nitroglycerin Therapy. Am J Ther. 1996 Nov; 3(11):766-770. PMID: 11862236.
-
Somberg JC. Rational therapeutics: dose titration and monotherapy in clinical practice. Am J Ther. 1996 Oct; 3(10):671. PMID: 11862221.
-
Khosla S, Somberg JC. Gender differences in drug therapy. Am J Ther. 1996 Oct; 3(10):735-9. PMID: 11862230.
-
Somberg JC. The FDA and Software. Am J Ther. 1996 Sep; 3(9):609-610. PMID: 11862299.
-
Somberg JC, Ichkhan K. Clinical Therapeutic Conference: Therapeutic Considerations in Atrial Fibrillation Management. Am J Ther. 1996 Sep; 3(9):658-660. PMID: 11862307.
-
Somberg JC. The Commercialization of Research. Am J Ther. 1996 Aug; 3(8):551. PMID: 11862289.
-
Somberg JC. Changing the Regulatory Process. Am J Ther. 1996 Jul; 3(7):477-478. PMID: 11862277.
-
Somberg JC. Histamine and Antihistamines: Clinical Pharmacology for the Practicing Physician. Am J Ther. 1996 Jul; 3(7):521-524. PMID: 11862284.
-
Somberg JC. Smoking, Smoking Cessation, and Regulation. Am J Ther. 1996 May; 3(5):333. PMID: 11862268.
-
Khosla S, Hentschel J, Somberg JC. Smoking Cessation Strategies. Am J Ther. 1996 May; 3(5):342-347. PMID: 11862270.
-
Khosla S, Duggal C, Somberg JC. Successful heart failure therapy is effective antiarrhythmia therapy. Am Heart J. 1996 May; 131(5):1048-50. PMID: 8615298.
-
Somberg JC. The Cancer Myth. Am J Ther. 1996 Apr; 3(4):259-260. PMID: 11862258.
-
Somberg JC. Nonphysician Prescribing. Am J Ther. 1996 Mar; 3(3):177. PMID: 11862247.
-
Somberg JC. Revisiting Adverse Drug Reactions. Am J Ther. 1996 Feb; 3(2):99. PMID: 11859378.
-
Somberg JC. Editorial: Inertia in Clinical Research. Am J Ther. 1996 Jan; 3(1):1-2. PMID: 11856990.
-
Somberg JC. The Promise of Chirality. Am J Ther. 1995 Dec; 2(12):909-910. PMID: 11854806.
-
Somberg JC. The Information Age and Therapeutics. Am J Ther. 1995 Nov; 2(11):827. PMID: 11854794.
-
Somberg JC. Clinical Therapeutic Conference: Thyroid Hormone Replacement in Hypothyroidism. Am J Ther. 1995 Nov; 2(11):900-905. PMID: 11854805.
-
Somberg JC. Off Label Indications. Am J Ther. 1995 Oct; 2(10):737-738. PMID: 11854779.
-
Somberg JC. Misoprostol and Eicosanoids: A New and Exciting Area of Therapeutics. Am J Ther. 1995 Sep; 2(9):589. PMID: 11854830.
-
Khosla S, Coutinho NB, Megellas MM, Mukherjee D, Somberg JC. Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia? Am J Cardiol. 1995 Aug 15; 76(5):337-9. PMID: 7639156.
-
Somberg JC. Smoking. Am J Ther. 1995 Aug; 2(8):523-524. PMID: 11854820.
-
Somberg JC. Clinical Therapeutic Conference: Sudden Death in a Young Athlete. Am J Ther. 1995 Aug; 2(8):581-585. PMID: 11854829.
-
Somberg JC. Proarrhythmia or Arrhythmogenicity. Am J Ther. 1995 Jul; 2(7):449. PMID: 11850689.
-
Somberg JC. A New Virus and the Adequacy of Public Health Methods. Am J Ther. 1995 Jun; 2(6):371. PMID: 11850679.
-
Somberg JC. Practice Guidelines, Consensus Conferences: The Pros and Cons. Am J Ther. 1995 May; 2(5):301. PMID: 11850666.
-
Somberg JC. Panel Discussion. Am J Ther. 1995 May; 2(5):347-358. PMID: 11850677.
-
Somberg JC. The Calcium Channel Blockers. Am J Ther. 1995 Apr; 2(4):231-232. PMID: 11850653.
-
Somberg JC. The Governmental Revolution. Am J Ther. 1995 Mar; 2(3):157. PMID: 11847545.
-
Somberg JC. Dismantling the FDA. Am J Ther. 1995 Feb; 2(2):79. PMID: 11847532.
-
Somberg JC. Editorial: Deferred Consent: Issues In Clinical Research. Am J Ther. 1995 Jan; 2(1):1. PMID: 11850639.
-
Somberg JC. Editorial: The Basis of Pharmaceutical Approval. Am J Ther. 1994 Dec; 1(4):253. PMID: 11835095.
-
Somberg JC. Clinical Therapeutic Conference. Am J Ther. 1994 Dec; 1(4):333-338. PMID: 11835108.
-
Somberg JC. Editorial: Therapeutics, Clinical Phamacology, Molecular Pharmacology: Have We Lost Our Academic Way? Am J Ther. 1994 Oct; 1(3):171-172. PMID: 11835083.
-
Somberg JC. Clinical Therapeutic Conference: Vancomycin Nephrotoxicity. Am J Ther. 1994 Oct; 1(3):245-251. PMID: 11835094.
-
Kerin NZ, Somberg J. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J. 1994 Sep; 128(3):575-85. PMID: 8074022.
-
Somberg JC. Pharmacoeconomics: These Changing Times. Am J Ther. 1994 Aug; 1(2):105-106. PMID: 11835073.
-
Somberg JC. To Begin Again. Am J Ther. 1994 Jun; 1(1):3. PMID: 11835059.
-
Martyn R, Somberg JC, Kerin NZ. Proarrhythmia of nonantiarrhythmic drugs. Am Heart J. 1993 Jul; 126(1):201-5. PMID: 8322665.
-
Somberg J, Shroff G, Khosla S, Ehrenpreis S. The clinical implications of first-pass metabolism: treatment strategies for the 1990s. J Clin Pharmacol. 1993 Jul; 33(7):670-3. PMID: 8366192.
-
Tullo NG, Landau S, Goldman I, Coutinho N, Somberg J. A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil. Acta Anaesthesiol Scand Suppl. 1993; 99:43-7. PMID: 8480506.
-
Somberg JC. Sharing regulatory review costs. J Clin Pharmacol. 1992 Oct; 32(10):867. PMID: 1447393.
-
Lavie E, Gergans G, Somberg JC. A comparison of tablets with oral suspension formulation of dipyridamole in thallium myocardial imaging. J Clin Pharmacol. 1992 Jun; 32(6):546-52. PMID: 1634642.
-
Freedman MD, Somberg JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991 Nov; 31(11):1061-9. PMID: 1753010.
-
Somberg J, Kreamer J, Camba N. Amiodarone therapy guided by electrophysiologic testing: an update. J Clin Pharmacol. 1991 Nov; 31(11):1089-95. PMID: 1753014.
-
Kreamer JW, Zevitz M, Somberg JC. The role of electrophysiologic testing in the selection of amiodarone therapy. J Clin Pharmacol. 1989 May; 29(5):429-35. PMID: 2661602.
-
Somberg JC. Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone. Am J Cardiol. 1987 Nov 15; 60(14):1218. PMID: 3687772.
-
Wyndham CR, Pratt CM, Mann DE, Winkle RA, Somberg J, de Maria AN, Josephson ME. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Am J Cardiol. 1987 Oct 16; 60(11):67F-72F. PMID: 3310588.
-
Somberg JC, Zanger D, Levine E, Tepper D. Encainide: a new and potent antiarrhythmic. Am Heart J. 1987 Oct; 114(4 Pt 1):826-35. PMID: 3116833.
-
Schwartz J, Crocker K, Wynn J, Somberg JC. The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44. PMID: 3630894.
-
Zempol P, Aogaichi K, Butler B, Tepper D, Somberg JC. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72. PMID: 3680596.
-
Somberg JC, Tepper D, Sacher H, Schwarz J. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25. PMID: 3111236.
-
Miura DS, Schwartz J, Laux B, Wynn J, Keefe D, Somberg JC. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6. PMID: 3654999.
-
Steinberg JS, Katz RJ, Somberg JC, Keefe D, Laddu AR, Burge J. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8. PMID: 2877563.
-
Anderson JL, Askins JC, Gilbert EM, Miller RH, Keefe DL, Somberg JC, Freedman RA, Haft LR, Mason JW, Lessem JN. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol. 1986 Oct; 8(4):752-62. PMID: 2428852.
-
Wynn J, Fingerhood M, Keefe D, Maza S, Miura D, Somberg JC. Refractory ventricular tachycardia with flecainide. Am Heart J. 1986 Jul; 112(1):174-5. PMID: 3728275.
-
Somberg JC, Miura D, Keefe DL. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76. PMID: 2424297.
-
Keefe DL, Miura D, Somberg JC. Supraventricular tachyarrhythmias: their evaluation and therapy. Am Heart J. 1986 Jun; 111(6):1150-61. PMID: 3521246.
-
Wynn J, Torres V, Flowers D, Mizruchi M, Keefe D, Miura D, Somberg J. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8. PMID: 3953384.
-
Somberg JC, Laux B, Wynn J, Keefe D, Miura DS. Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53. PMID: 3953387.
-
Miura DS, Wynn J, Torres V, Laux B, Keefe D, Somberg JC. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6. PMID: 3513503.
-
Keefe DL, Williams S, Torres V, Flowers D, Somberg JC. Prophylactic tocainide or lidocaine in acute myocardial infarction. Am J Cardiol. 1986 Mar 01; 57(8):527-31. PMID: 3082175.
-
Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7. PMID: 3941202.
-
Morganroth J, Somberg JC, Pool PE, Hsu PH, Lee IK, Durkee J, Salerno DM. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16. PMID: 3079781.
-
Wynn J, Miura DS, Torres V, Flowers D, Keefe D, Williams S, Somberg JC. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81. PMID: 2414983.
-
Torres V, Flowers D, Somberg J. The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. Am Heart J. 1985 Jul; 110(1 Pt 1):17-24. PMID: 4013979.
-
Torres V, Flowers D, Somberg JC. The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7. PMID: 3993517.
-
Miura DS, Keren G, Torres V, Butler B, Aogaichi K, Somberg JC. Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33. PMID: 3984837.
-
Somberg JC, Butler B, Torres V, Tepper D, Keren G, Siegel L, Jentzer J, Miura DS. Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90. PMID: 3896040.
-
Brazzell RK, Colburn WA, Aogaichi K, Szuna AJ, Somberg JC, Carliner N, Heger J, Morganroth J, Winkle RA, Block P. Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86. PMID: 3995859.
-
Somberg J, Tepper D, Wynn J. Prolonged repolarization: a historical perspective. Am Heart J. 1985 Feb; 109(2):395-8. PMID: 3966368.
-
Somberg J, Butler B, Flowers D, Tepper D, Torres V. Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36. PMID: 3879419.
-
Flowers D, O'Gallagher D, Torres V, Miura D, Somberg JC. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83. PMID: 3966401.
-
Somberg J. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48. PMID: 2866841.
-
Somberg J, Torres V, Flowers D, Miura D, Butler B, Gottlieb S. Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27. PMID: 3871296.
-
Somberg J, Butler B, Flowers D, Keefe D, Torres V, Miura D. Long-term lorcainide therapy in patients with ventricular tachycardia. Am Heart J. 1985 Jan; 109(1):33-40. PMID: 3966330.
-
Torres V, Flowers D, Miura D, Somberg J. Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia. Am Heart J. 1984 Dec; 108(6):1437-42. PMID: 6507239.
-
Keren G, Tepper D, Butler B, Torres V, Somberg JC. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Am Heart J. 1984 Nov; 108(5):1236-43. PMID: 6333809.
-
Keren G, Tepper D, Butler B, Miura D, Aogaichi K, Somberg J. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog. J Clin Pharmacol. 1984 Oct; 24(10):466-72. PMID: 6511989.
-
Somberg JC, Torres V. New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainide. Am J Cardiol. 1984 Aug 13; 54(4):1B. PMID: 6465042.
-
Somberg JC. New directions in antiarrhythmic drug therapy. Am J Cardiol. 1984 Aug 13; 54(4):8B-17B. PMID: 6147082.
-
Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B. PMID: 6465047.
-
Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B. PMID: 6465046.
-
Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS. Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B. PMID: 6465045.
-
Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Wynn J, Keren G, Miura DS. Antiarrhythmic action of bethanidine. Am J Cardiol. 1984 Aug 01; 54(3):343-6. PMID: 6465015.
-
Somberg JC. New approaches to drug selection and serial drug testing. J Clin Pharmacol. 1984 Jul; 24(7):320-7. PMID: 6207209.
-
Keren G, Miura DS, Somberg JC. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43. PMID: 6702556.
-
Brazzell RK, Aogaichi K, Heger JJ, Somberg JC, Carliner NH, Morganroth J. Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16. PMID: 6697638.
-
Spivack C, Gottlieb S, Miura DS, Somberg JC. Flecainide toxicity. Am J Cardiol. 1984 Jan 15; 53(2):329-30. PMID: 6695731.
-
Somberg JC, Knox SM, Miura DS. Effect of quinidine on differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis in dogs. Am J Cardiol. 1983 Nov 01; 52(8):1123-6. PMID: 6637835.
-
Somberg JC, Bounous H, Cagin N, Levitt B. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug; 214(2):375-80. PMID: 6104726.
-
Somberg JC, Bounous H, Levitt B. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol. 1979 Feb 15; 54(1-2):161-6. PMID: 421737.
-
Cagin NA, Benda R, Somberg J, Levitt B. Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual. N Y State J Med. 1978 May; 78(6):888-9. PMID: 418364.
-
Levitt B, Cagin N, Kleid J, Somberg J, Gillis R. Role of the nervous system in the genesis of cardiac rhythm disorders. Am J Cardiol. 1976 Jun; 37(7):1111-3. PMID: 1274874.
-
Levitt B, Cagin NA, Somberg JC, Kleid JJ. Neural basis for the genesis and control of digitalis arrhythmias. Cardiology. 1976; 61(1):50-60. PMID: 975124.
-
Cagin NA, Somberg J, Bounous H, Mittag T, Raines A, Levitt B. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7. PMID: 4827418.